Variation in perioperative vasoactive therapy in cardiovascular surgical care: Data from the Society of Thoracic Surgeons
Variation in perioperative vasoactive therapy in cardiovascular surgical care: Data from the Society of Thoracic Surgeons
复制标题
DOI：
10.1016/j.ahj.2009.05.014
复制
发表时间：
2009-07-01
影响因子：
4.8
通讯作者：
Peterson, Eric D.
中科院分区：
文献类型：
--
作者：
Hernandez, Adrian F.;Li, Shuang;Peterson, Eric D.
背景在高危冠状动脉搭桥术（CABG）患者中适当使用血管活性心血管药物尚未得到很好的描述。方法我们对2004年1月至2005年6月期间在55家胸外科学会全国成人心脏外科数据库中随机选择的2390例接受CABG的患者进行了详细的图表分析。如果患者有选择性/紧急冠脉搭桥，射血分数(EF) = 65年，伴有糖尿病，或肾小球滤过率
Background The appropriate use of vasoactive cardiovascular drugs in high-risk coronary artery bypass grafting (CABG) patients has not been well characterized.Methods We performed a detailed chart analysis on 2,390 randomly selected patients undergoing CABG between January 2004 and June 2005 at 55 hospitals participating in the Society of Thoracic Surgeons' National Adult Cardiac Surgery Database. Patients were eligible if they had elective/urgent CABG with an ejection fraction (EF) = 65 years with diabetes, or a glomerular filtration rate